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Abstract
Background: The laboratory mouse is commonly used as a sophisticated model in biomedical research.
However, experiments requiring major surgery frequently lead to serious postoperative complications and
death, particularly if genetically modified mice with anatomical and physiological abnormalities undergo
extensive interventions such as transmitter implantation. Telemetric transmitters are used to study
cardiovascular physiology and diseases. Telemetry yields reliable and accurate measurement of blood
pressure in the free-roaming, unanaesthetized and unstressed mouse, but data recording is hampered
substantially if measurements are made in an exercising mouse. Thus, we aimed to optimize transmitter
implantation to improve telemetric signal recording in exercising mice as well as to establish a
postoperative care regimen that promotes convalescence and survival of mice after major surgery in
general.
Results:  We report an optimized telemetric transmitter implantation technique (fixation of the
transmitter body on the back of the mouse with stainless steel wires) for subsequent measurement of
arterial blood pressure during maximal exercise on a treadmill. This technique was used on normal
(wildtype) mice and on transgenic mice with anatomical and physiological abnormalities due to constitutive
overexpression of recombinant human erythropoietin. To promote convalescence of the animals after
surgery, we established a regimen for postoperative intensive care: pain treatment (flunixine 5 mg/kg
bodyweight, subcutaneously, twice per day) and fluid therapy (600 μl, subcutaneously, twice per day) were
administrated for 7 days. In addition, warmth and free access to high energy liquid in a drinking bottle were
provided for 14 days following transmitter implantation. This regimen led to a substantial decrease in
overall morbidity and mortality. The refined postoperative care and surgical technique were particularly
successful in genetically modified mice with severely compromised physiological capacities.
Conclusion: Recovery and survival rates of mice after major surgery were significantly improved by
careful management of postoperative intensive care regimens including key supportive measures such as
pain relief, administration of fluids, and warmth. Furthermore, fixation of the blood pressure transmitter
provided constant reliable telemetric recordings in exercising mice.
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Background
Laboratory mice are currently the most common mamma-
lian model for basic and applied biomedical research.
Inbred and mutant mice are also universally accepted in
the study of inherited human disorders. Thus, mice are
widely used for complex investigations requiring addi-
tional surgical interventions that are often associated with
considerably high levels of morbidity and mortality of the
animals. This results mainly from the adverse effects of
surgery and trauma, which can be exacerbated by inade-
quate anaesthesia methodology. The present study
focused on refinement strategies aimed at increasing the
survival rate in mice after major surgery, using telemetric
transmitter implantation as a practical and useful exam-
ple.
Radiotelemetry is a unique methodology used to measure
cardiovascular parameters in unanaesthetized, freely mov-
ing small rodents. Using this method, physiological
parameters can be efficiently and accurately recorded,
allowing reliable and objective results to be established
[1-6]. Studying cardiovascular physiology is an important
tool in drug development, safety, pharmacology and fur-
ther research goals [4]. Thus, the ability to record cardio-
vascular parameters in mice has become an important
tool in understanding the response of the cardiovascular
system in various experimental approaches [7]. Under cer-
tain circumstances, it is necessary to investigate cardiovas-
cular performance under challenging physical conditions.
Treadmill exercise tests, which induce cardiovascular
stress in order to detect cardiovascular abnormalities that
may not be observed at rest, are a commonly used clinical
approach in human beings [8]. Metabolic parameters are
often determined simultaneously by indirect calorimetry
during exercise in man [9]. In contrast to the situation in
humans, cardiovascular function and metabolic parame-
ters have been measured only rarely in rodents during
submaximal and maximal exercise – the main reasons
being the high cost of the necessary equipment and the
need for experience in microsurgical techniques for probe
implantation. In the case of arterial blood pressure trans-
mitters, the pressure-sensing catheter tip is usually
implanted in the thoracic aorta via the left carotid artery,
and the transmitter body is placed subcutaneously along
the right flank [1]. Thus, the animals have to carry the
weight of the transmitter unilaterally. This is particularly
uncomfortable during exercise, resulting in abandonment
of the exercise test. Moreover, only weak telemetric signals
or even no signals at all are obtained during treadmill
exercise due to the distance between the transmitter
(located on the mouse's flank) and the receiver plate
(placed over the treadmill). Furthermore, in spite of
advancements in surgical techniques in recent years, mor-
bidity and mortality remain high if telemetric transmitters
are implanted in mice. Due to their specific phenotypical
characteristics, mice often react with severe impairment of
their general condition and symptoms of suffering as a
result of the trauma of implantation [10,11]. Thus, even if
the surgical procedure appears to be successful, optimized
perioperative conditions (e.g. safe and controllable anaes-
thesia) and intensive postoperative medical care are essen-
tial to prevent severe physiological aberrations and death
after transmitter implantation. Obviously, such support-
ive measures are especially important in genetically mod-
ified mice with pre-existing bodily abnormalities or
compromised compensation potential.
Here we present a detailed systematic intensive care regi-
men that can be applied after major surgery in mice. The
beneficial effects on survival rate were validated in the
transgenic mouse line C57BL/6-TgN(PDGFBEPO)321Zbz
(tg6), which constitutively overexpresses human erythro-
poietin (Epo) cDNA, and in corresponding inbred wild
type (wt) mice [12,13]. Moreover, we have developed an
alternative implantation technique for telemetric blood
pressure transmitters, namely to place the transmitter
body in the midline of the mouse's back. This approach
aimed to minimize the negative impact of transmitter
weight on running performance while still allowing tele-
metric signals to be obtained in a constant and reliable
manner during maximum exercise.
Results
Standardization of implantation technique
All implantations were carried out by the same experi-
menter, who was skilled and experienced in microsurgery
and implantation of devices in mice for long-term survival
experiments. In a preliminary pilot experiment (see
below), the implantation methodology (including sup-
portive measures during implantation) was established
and practiced until the technique was optimized and
highly reproducible.
Implantation of blood pressure transmitters
The implantations were carried out in a laminar flow
hood equipped with a surgical microscope. Aseptic condi-
tions were assured by the use of autoclaved instruments
and sterilized materials. Inhalation anaesthesia was initi-
ated and maintained, respectively, with 7–8% and 3.5–
4% sevoflurane (Sevorane®, Abbot, Cham, Switzerland) in
O2. During anaesthesia, the animal's eyes were protected
with ointment (Vitamine A, Bausch & Lomb, Steinhausen,
Switzerland). After shearing of hairs and disinfection of
the anterior neck region, a longitudinal skin incision of 1
cm was performed, the connective tissues and muscles
were prepared and the left common carotid artery (Arteria
carotis communis sinistra) was exposed. The artery was
ligated with a silk suture (PERMA-Handseide, 6-0,
Ethicon, Norderstedt, Germany) at its bifurcation at both
the internal and external branches. A second silk suture
was placed around the artery at a distance of 4–6 mm cau-
dal of the bifurcation and the blood flow was stopped byBMC Veterinary Research 2009, 5:28 http://www.biomedcentral.com/1746-6148/5/28
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retracting the suture. A third silk suture was bound loosely
around the artery between the other two. Then, a hole was
cut in the artery using fine-bladed scissors and the catheter
of a TA11PA-C10 transmitter (DataSciences International,
St. Paul, MN, USA) was inserted into the vessel. The mid-
dle silk suture was tightened and the retracting, caudal
thread was released to allow the tip of the catheter to be
advanced into the thoracic aorta. The catheter was then
secured in the carotid artery by knotting the silk sutures.
The muscles and connective tissues were restored with
absorbable sutures (VICRYL 6-0, Ethicon, Norderstedt,
Germany). A pocket between the skin and the muscle lay-
ers was prepared by blunt dissection with atraumatic scis-
sors. This pocket in the subcutaneous connective tissues
reached from the right edge of the skin incision to the
back of the mouse. The transmitter body was inserted into
the pocket at the right edge of the skin incision and then
advanced in a dorsal direction until it was located subcu-
taneously on the upper back. The transmitter body was
then fixed with 3–4 loops of surgical stainless steel sutures
(EH 7623G, 3-0; Ethicon, Norderstedt, Germany), which
were laid from one side to the other through the skin in
the subcutaneous connective tissues underneath the trans-
mitter body. One to two loops of stainless steel wire were
placed behind the transmitter body to prevent its disloca-
tion to the lower back. Finally, the skin incision in the
neck was closed with absorbable sutures and anaesthesia
was stopped. Throughout the entire study, the time
required for anaesthesia and implanting the transmitter in
each individual was routinely 50–60 min.
Supportive measures during implantation
The laminar flow work bench on which the mouse was
laid during surgery was equipped with a water-bath-
heated surface set at 38°C to avoid any drop in the
mouse's body temperature due to anaesthesia. When
anaesthesia was withdrawn, the conscious animal was
allowed to recover for 2–3 hours on the warmed surface
(during which time it could move freely under a wire
mesh grid) before being transferred back to its home cage.
To support fluid homeostasis during surgery, 1 mL of
saline (0.9%) at a temperature of 36°C was injected intra-
peritoneally shortly after induction of anaesthesia. This
was also intended to prevent hypovolemia and hypoten-
sion in the case of substantial blood loss from possible
bleeding during surgery.
As anti-infective prophylaxis, Sulfadoxin and Trimetho-
prim were injected intraperitoneally at a dosage of 30 and
6 mg/kg bodyweight, respectively, before starting surgery.
Analgesics
Either buprenorphine (Temgesic®, 0.1 mg/kg body weight;
Essex Chemie AG, Lucerne, Switzerland) or flunixine
(Biokema Flunixine®, 5 mg/kg body weight; Biokema SA,
Crissier-Lausanne, Switzerland) was applied. Analgesics
were administered subcutaneously twice per day (i.e.
every 12 hours) for 7 days; the first injection of analgesics
was performed during transmitter implantation.
Postoperative analgesia and care regimens
All animals recovered within 10–15 min after cessation of
inhalation anaesthesia, and showed undisturbed moving
behaviour, self grooming, and occasional climbing at 1–2
hours after implantation. All mice were active and in good
general condition when transferred to their home cage 2–
3 hours after implantation was completed.
Mice in the first two groups were transferred back to stand-
ard housing conditions (described below) 2–3 hours after
implantation was complete. In the first group, pain was
alleviated with buprenorphine (wt: n = 2, tg6: n = 2); in
the second group flunixine was used as analgesic (wt: n =
1, tg6: n = 4). No further postoperative measures were
applied in these animals. All animals from these two
groups were found moribund with severe symptoms of
hypothermia, apathy, and exsiccosis at 1–14 days after
implantation. The wt mice in the first and second group
had a mean survival time of 9 days, whereas the tg6 mice
had a mean survival time of 4 days after implantation.
Animals treated with the opioid buprenorphine (first
group) had a mean survival time of 4 days, whereas treat-
ment with the non-steroidal anti-inflammatory drug flu-
nixine (second group) showed a tendency towards longer
survival, with a mean survival time of 7 days.
Necropsy and transmitter explantation both confirmed
that the implantation per se was optimal, with no signs of
specific complications (e.g., bleeding, necrosis, inflamma-
tion, wound dehiscence, or entrapment of legs or teeth in
a wire loop). Further systematic pathological investigation
revealed no abnormalities and no hints of side effects
from the different types of pain killers used. It was
assumed that the prolonged deficiency in energy and fluid
intake combined with the extended postoperative energy
demand and temperature loss were the causes underlying
the deterioration in bodily functions and fatal outcome in
the first two groups.
The results from the first two groups led us to develop
improvements in the postoperative care regimen focussed
on resolving the energy and fluid deficiencies and sup-
porting maintenance of normal body temperature.
A third group (wt: n = 47, tg6: n = 48) received flunixine
for pain relief and an additional fluid therapy of 300 μl
glucose (5%) and 300 μl saline (0.9%), injected subcuta-
neously twice per day for 7 days. All analgesic agents
including glucose liquid and saline were warmed to body
temperature before injection. For this third group, all ani-
mal cages were kept on a heating mat during the entire 2-BMC Veterinary Research 2009, 5:28 http://www.biomedcentral.com/1746-6148/5/28
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week postoperative period. In addition, unlike the first
two groups, the third group had free access to glucose
(15%), offered in a second drinking bottle, and to a high-
energy wet food (Solid Drink®-Energy, Triple A Trading,
Tiel, Netherlands). The high-energy food and the glucose-
containing bottle were provided in the animals' cages
from 2 to 3 days before surgery until 2 weeks afterwards.
In addition, O2 was piped into the cages for two weeks
after implantation.
In contrast to the animals of the first and second group,
no animal in the third group showed postoperative com-
plications such as hypothermia, apathy, or exsiccosis.
Four tg6 mice developed haematoma in the right neck and
shoulder area at 1–2 hours after surgery. Three of these
animals could be rescued by re-opening the wound and
removing the blood clots, while additional warm saline (1
mL) was injected intraperitoneally. Despite removing the
haematoma, one of these animals was sacrificed 6 days
after implantation because of repeated bleeding at the
implantation site. Finally, 94 out of 95 mice in group 3
were healthy and in good physical condition at the end of
the 14-day postoperative period.
Later, three wt mice were sacrificed between 23 and 30
days after implantation as these animals were fighting
with their female companions and showed severe skin
injuries. Two tg6 mice were sacrificed 23 and 41 days after
implantation because the telemetric signals hinted at
signs of blood clot formation at the tip of the catheter (i.e.
damped blood pressure curves). This was confirmed dur-
ing necropsy. Despite these limitations, the methodology
applied to group 3 was rather successful, as shown by the
relationship between postoperative treatment and sur-
vival time (Figure 1). The postoperative intensive care reg-
imen established in the third group was associated with
survival times of 30–56 days, which was the final end-
point of the study and the point at which the animals were
sacrificed after having exercised on the treadmill.
Survival time vs. body weight
Animals underwent implantation of telemetric transmit-
ters at the age of 4–5 weeks (mean 30.9 days, standard
deviation ± 2.7 days). Mice were weighed on the day of
implantation (before implantation started) and on the
day on which they were sacrificed. Body weight was
recorded with a precision balance (PR 2003 Delta Range,
Mettler-Toledo AG, Greifensee, Switzerland) especially
calibrated for use with moving animals. Body weights
were corrected to take into account the weight of the trans-
mitter (1.4 g). All weighing procedures were performed at
the same time of day (07:00–08:00 a.m.).
Postoperative intensive care (administration of analgesics and fluid, warmth) improves long-term survival Figure 1
Postoperative intensive care (administration of analgesics and fluid, warmth) improves long-term survival. Each 
value represents a single animal.
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On the day of implantation, body weights ranged from 18
g to 27 g (wt: mean 21.6, standard deviation ± 1.6; tg6:
mean 22.2, standard deviation: ± 2.1). There was no cor-
relation between an individuals' body weight at implanta-
tion and their survival time. Mice that did not survive
more than 2 weeks were around average body weight, or
even slightly above-average weight, at implantation (Fig-
ure 2). The final body weight of mice that did not survive
more than 2 weeks was decreased in the tg6 mice but not
in wt animals. Thus, the final body weight was not clearly
correlated with survival time. The final body weight of the
94 mice that survived >3 weeks showed that they gained
weight over time, as would be expected with increasing
age and bodily development (Figure 3).
Long-term effects of transmitter fixation
In all animals, the transmitter body was fixed in the mid-
line of the mouse's back (Figure 4). In two animals from
the third group, the transmitter body had to be re-fixed
the day after implantation because it had turned and
moved to the upper neck region, where it could hamper
the movement of the mouse's head. In general, the mice
showed no signs of reduced physical activity or restricted
head movement. In contrast to the implantation tech-
nique usually used, where the transmitter body hangs
loosely at the lateral body side, fixation with stainless steel
wires on the animal's back allowed reliable detection of
the telemetric signal, as the distance between the telemet-
ric receiver plate and the transmitter body is shortened
(Figure 5).
An individual's body weight at implantation is not correlated with its survival time Figure 2
An individual's body weight at implantation is not correlated with its survival time. Ten mice with high body weight 
(21–25 g) did not survive 14 days after implantation; nine of these (triangles and diamonds) represent animals that did not 
receive postoperative fluid support and warmth. One transgenic mouse (open circles) received postoperative intensive care 
but was sacrificed 6 days after surgery because of repeated bleeding (probably promoted by the impaired blood coagulation 
properties of the tg6 mouse line). The remaining 94 mice benefited from postoperative intensive care as they survived and 
were in a healthy condition at >3 weeks after implantation, regardless of body weight at implantation [even the 14 mice that 
had particularly low body weight (<20 g) at implantation].
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Telemetric signal verification during maximal exercise
The reliability of constant telemetric signaling during
maximal exercise was demonstrated in 89 mice at 30–56
days after implantation (Figure 6). The telemetric signal
was measured during maximal exercise using a Simplex II
metabolic rodent treadmill, fitted with an Oxymax gas
analyzer (Columbus Instruments, Columbus, OH, USA).
For the maximal incremental exercise test, mice were
placed in the exercise chamber and allowed to equilibrate
for 30 min. Treadmill activity was initiated at 2.5 m/min
and 0° inclination for 10 min, and then increased by 2.5
m/min and 2.5° every 3 min thereafter until exhaustion.
Mice were gently encouraged to run for as long as possible
by the use of a mild electric grid at the end of the treadmill
(0.2 mA, pulse 200 ms, 1 Hz). Exhaustion was defined as
the inability to continue regular treadmill running despite
a repeated electric stimulus to the mice. Accurate arterial
blood pressure curves with minimal artefacts were
recorded during maximal exercise on the treadmill in all
mice tested.
Discussion
Our goal of using genetically modified mice with compro-
mised phenotype for performing maximum exercise while
obtaining real-time blood pressure measurements was
realized by elaborating refined methods for telemetric
transmitter implantation and postoperative intensive
care.
Final body weight in relation to survival time Figure 3
Final body weight in relation to survival time. Each value represents a single animal. Compared to the time point of 
implantation, the transgenic mice (tg6) without postoperative intensive care (open triangles and diamonds) or permanent 
bleeding, lost body weight, whereas the 3 wildtype (wt) mice (filled triangles and diamonds) without postoperative intensive 
care maintained or even increased their body weight, although they did not survive 14 days after implantation. Thus, the 
progress of the individuals' body weight in the 2-week, critical postoperative period could not be taken as a reliable indicator 
for assessing the quality of convalescence and for anticipating survival. The mean body weight of 94 mice that received postop-
erative intensive care and survived for more than 3 weeks was increased from 22 g (standard deviation ± 2) at implantation, to 
a final weight of 25 g (standard deviation ± 2) on average. The long-term gain of body weight confirmed that the animals were 
healthy and in good bodily condition for exercising on the treadmill, and that they tolerated the transmitter well.
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When telemetric transmitters for measuring blood pres-
sure in mice first became available, a technique for
implantation was developed in which the catheter was
implanted in the abdominal aorta and the transmitter
body was located in the abdominal cavity [14-16]. This
implantation method had limited success because it
induced thrombosis and embolism at high rates, which
finally led to the death of more than half of the mice
implanted within 2 days of surgery. Therefore, implanta-
tion of the catheter in the thoracic aorta arch via the com-
mon carotid artery soon became the method of choice.
Because of the limited length of the catheter, the transmit-
ter body had to be placed under the skin of the back, from
where it moved usually to the right body wall of the
mouse [1,17]. Thus, fixation of the transmitter body with
threads attached to the muscles of the animal's back was
proposed, but caused difficulties and additional injury,
because a second skin incision at the shoulder region was
necessary in addition to the one in the anterior neck (used
for placement of the catheter) [1]. Thus, it was generally
preferred that the transmitter body was introduced via the
wound at the anterior neck to the right flank, without any
further fixation. This technique, in which the transmitter
body hung at the lateral body wall of the mouse, seemed
feasible for recordings at rest and during performance of
an incremental exercise test, e.g. for about 15 minutes of
treadmill running [18]. However, we found in a previous
experiment (data not shown) that transmitter signals were
either weak, undetectable or disturbed by artefacts during
incremental exercise to exhaustion on a treadmill. Moreo-
ver, the lateral placement of the transmitter body, which
lay in front of the right hind leg, seemed to hamper move-
ment and consequently the exercise performance of the
animal. Thus, we inserted the transmitter body through
the wound in the neck under the skin of the back, approx-
imately onto the shoulders. Stainless steel wire loops
between the transmitter and the connective tissue fixed it
in the midline over the axis. Placement of one or two
loops behind the transmitter body prevented it from mov-
ing to the lower back and avoided the possibility that the
catheter tip could be withdrawn from the aortic arch. Any
drawbacks of this method were apparent only in the
genetically modified mice, in which tissue damage from
suturing with wires or injury to subcutaneous vessels
when preparing the pocket for the transmitter led to pro-
longed bleeding due to the impaired blood clotting prop-
erties of these transgenic mice (which is a result of the
genetic modification). As a consequence, prominent hae-
matoma appeared in the area of the right shoulder and the
neck shortly after surgery had been completed. Removing
the haematoma by re-opening the wound in the neck and
using an intraperitoneal injection of additional saline res-
cued three out of four of these mice, while one was sacri-
ficed six days after implantation because of repeated
Radiographs showing the position of the telemetry transmit- ter from a dorsal (left) and lateral (right) viewpoint Figure 4
Radiographs showing the position of the telemetry 
transmitter from a dorsal (left) and lateral (right) 
viewpoint. The transmitter body was placed in the midline 
of the mouse's back and fixed with surgical stainless steel 
sutures.
Treadmill with telemetry receiver plate Figure 5
Treadmill with telemetry receiver plate. The arrow 
marks the distance between the running belt of the treadmill 
and the receiver plate. The secure fixation of the transmitter 
body on the back of the mouse allowed reliable, constant 
recording of blood pressure curves from mice during maxi-
mal exercise.BMC Veterinary Research 2009, 5:28 http://www.biomedcentral.com/1746-6148/5/28
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bleeding and hypovolemia. Other than these specific
transgenic animals, three wt mice were sacrificed before
reaching the final time point of the experiment because
they sustained serious injuries after fighting with their
female cage mates. In these cases, as well as in the two
transgenic mice with thrombus formation at the catheter
tip, there was no direct relationship between the earlier
scarification time point and the new transmitter body
implantation technique. Overall, fixation of the transmit-
ter at the upper back of the mouse allowed us to measure
reliable telemetric signals at any time point during maxi-
mum exercise.
The use of genetically modified mice with phenotypes
that hint at deficiencies in physiological and bodily adap-
tion capacities is increasing. Such disabilities in the tg6
mice specifically hampered our surgical efforts in the first
part of our study, i.e., the tg6 mice in the first and second
group had shorter survival times (average 4 days) com-
pared to the wt, which survived on average 9 days. How-
ever, all mice in the first and second groups showed clear
symptoms of exsiccosis, hypothermia, and energy deficit,
which led to a severely depressed general condition and
overall appearance. Subsequently, we introduced addi-
tional supportive postoperative measures to improve the
recovery of the animals, which led to a high survival rate.
We found no relationship between body weight and sur-
vival rate, as has been suggested by others [19]; even mice
with body weights below 20 g survived implantation
without complications if postoperative intensive care was
Representative examples of original data of blood pressure measurements at rest and during maximal exercise (exhaustion) on  the treadmill Figure 6
Representative examples of original data of blood pressure measurements at rest and during maximal exer-
cise (exhaustion) on the treadmill. The upper row shows 10-second intervals, the lower row represents 1-second inter-
vals cut from the above sample. Typical arterial blood pressure waveforms with a visible dichrotic notch (arrow) were obtained 
from the same tg6 mouse, with almost no artefacts. At rest, mean values (calculated from 10-second intervals) were as follows: 
systolic blood pressure 115 [standard deviation (SD) 3.0] mmHg; diastolic blood pressure 86 (SD 2.4) mmHg; heart rate 555 
(SD 2.4) beats per minute. At exhaustion, mean values (calculated from 10-second intervals) were: systolic blood pressure 170 
(SD 0.9) mmHg; diastolic blood pressure 135 (SD 0.7) mmHg; heart rate 750 (SD 0.01) beats per minute.
arterial pressure curves
at rest
0.1 sec 0.1 sec
1 sec 1 sec
arterial pressure curves
at exhaustion
arterial pressure curves
at rest
0.1 sec 0.1 sec
1 sec 1 sec
arterial pressure curves
at exhaustionBMC Veterinary Research 2009, 5:28 http://www.biomedcentral.com/1746-6148/5/28
Page 9 of 11
(page number not for citation purposes)
provided. Also, we propose that providing warmth for a
prolonged period of 14 days after implantation was bene-
ficial, because this would save energy for the animal, as
also proposed by others [20]. In addition, we consider
that injection of warmed fluid at 12 hour intervals for
seven days was a key intervention supporting survival.
Indeed, although this intervention subjects the animals to
some additional stress, the positive effect of this therapy
appears to far outweigh the risks. Finally, we suggest offer-
ing glucose (15%) in a drinking bottle because we
observed that the animals consumed the sweet liquid in
large amounts postoperatively, thus providing themselves
with a continuous source of additional energy and fluid.
Using a combination of the above measures, we were able
to overcome the complications and poor success rate of
previous implantation methods, since neither wt nor tg6
mice showed the marked symptoms of depressed general
condition and health if implantation was followed by
intensive care. As a consequence, almost all the mice in
group 3 reached the predefined final time point of the
study several weeks after implantation. The postoperative
intensive care and analgesia regimens described here may
be useful for others confronted with similar difficulties
when implanting probes or conducting major surgery in
mice.
Conclusion
The present findings show that postoperative care, includ-
ing pain relief, administration of fluids, and warmth,
improves recovery and survival after implantation of
probes, which is particularly important in genetically
modified mice with impaired bodily capacities. Although
our regimen was established for a specialized type of sur-
gery (implantation of telemetric blood pressure transmit-
ters), the optimized postoperative analgesia and intensive
care regimen detailed here may be applicable to many
other potentially risky or traumatic surgical interventions.
The improvement of the implantation technique by place-
ment and secure subcutaneous mounting of the transmit-
ter body on the upper back of the mouse is crucial to the
recording of telemetric signals in the exercising mouse.
Thus, even in mice running to exhaustion on the incre-
mental enclosed metabolic treadmill, continuous reliable
measurement of cardiovascular function can be achieved.
Methods
Ethical review
Each step of the project was approved by the Cantonal
Veterinary Department, Zurich, Switzerland, under
license number 35/2006. First, preliminary permission for
a pilot experiment was approved. In the pilot experiment,
the implantation procedure and the perioperative treat-
ment were monitored during site visits by members of the
ethical committee and the responsible cantonal veterinar-
ian. Thereafter, the study was fully approved by the
authorities. The study was further closely supervised by
the ethical committee, the animal welfare officer, and the
responsible cantonal veterinarian. In regular site visits,
records were controlled, experiments were observed, and
modifications to postoperative care were discussed and
accepted by the authorities. Written statements from
members of the ethical committee and the cantonal veter-
inary department documented compliance with the ethics
of conducting animal experiments in accordance with
Swiss Animal Protection Law.
Housing and experimental procedures also conform to
the European Convention for the protection of vertebrate
animals used for experimental and other scientific pur-
poses (Council of Europe nr.123 Strasbourg 1985) and to
the Guide for the Care and Use of Laboratory Animals (Insti-
tute of Laboratory Animal Resources, National Research
Council, National Academy of Sciences, 1996).
Preliminary pilot experiment
The surgical techniques necessary for the implantation of
blood pressure transmitters in inbred mice of variable
body weight had been established and standardized prior
to the present study. In a preliminary pilot experiment,
the anaesthesia and surgery methodologies, including
supportive measures during implantation, were opti-
mized and practiced in several wt and tg6 mice (data not
shown). At the end of the pilot experiment, the implanta-
tion and perioperative procedures were audited and
approved by official experts on behalf of the ethical com-
mittee.
At the start of the study, the protocol for implantation
including supportive measures was standardized as
described above. Subsequent postoperative treatment (>1
day after implantation) relied on the experience of
implantation of other types of telemetric transmitters in
hundreds of mice in our laboratory. Thus, at the time
point when the present study began, our routine post-
operative care after the animal was transferred back to its
cage consisted mainly of administering a pain killer
(either an opioid or a non-steroidal anti-inflammatory
drug) twice per day.
Generation and phenotype of erythropoietin-
overexpressing mice
The transgenic mice were generated by pronuclear micro-
injection of the full-length human Epo cDNA driven by
the human platelet-derived growth factor B-chain pro-
moter as described previously [12]. The resulting mouse
line B6D2-TgN(PDGFBEPO)321Zbz was backcrossed for
10 generations in a pure C57BL/6 background, resulting
in the C57BL/6-TgN(PDGFBEPO)321Zbz line, also
termed tg6. In general, breeding was performed by mating
hemizygous tg6 males to wt C57BL/6 females. AsBMC Veterinary Research 2009, 5:28 http://www.biomedcentral.com/1746-6148/5/28
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expected, one half of the offspring was hemizygous for the
transgene while the other half was wt and served as con-
trols.
Tg6 mice have a Epo plasma level elevated 10- to 12-fold
compared to the corresponding controls [12]. Although
plasma volume was unaltered, the blood volume of the
transgenic animals was nearly doubled. The enormous
hematocrit values of up to 0.9 (normal 0.4) strain the
heart, and consequently heart weight was markedly
increased [21]. On the other hand, blood pressure, heart
rate and cardiac output were not altered in tg6 mice. How-
ever, bleeding time was significantly prolonged in these
transgenic animals [22]. Adaptive mechanisms to exces-
sive erythrocytosis include increased plasma nitric oxide
levels and erythrocyte flexibility [12,23]. Recently, it was
shown that erythrocyte half-lives in the transgenic ani-
mals were 70% lower than in wt controls [24]. Although
the tg6 mice grew normally, as a consequence of the adap-
tive mechanisms, the lifespan of these transgenic mice was
one-third that of their wild type siblings [21].
Animals and standard housing conditions
A total of 50 wt and 54 tg6 male mice were obtained from
our in-house breeding colony. The mice were free of the
viral, bacterial, and parasitic pathogens listed in the rec-
ommendations of the Federation of European Laboratory
Animal Science Association [25]. Their health status was
monitored by a sentinel program throughout the experi-
ments.
Male tg6 and wt mice were housed individually from 1
week before until 2 weeks after implantation. Later, each
male was housed together with an ovariectomized female
to avoid the cardiovascular implications of social isola-
tion from long-term single housing as well as the perma-
nent stress and severe injuries that can arise from
aggression and fighting – which occur frequently in
groups of adult male mice.
All mice were kept in standard rodent cages with auto-
claved dust-free sawdust bedding. They were fed a pelleted
mouse diet (Kliba No. 3431, Provimi Kliba, Kaiseraugst,
Switzerland) ad libitum and had unrestricted access to
sterilized drinking water. The light/dark cycle in the room
consisted of 12/12 h with artificial light (approx. 40 Lux
in the cage) from 3.00 a.m. to 3.00 p.m. The temperature
was 21 ± 1°C, with a relative humidity of 50 ± 5%, with
15 complete changes of filtered air per hour (HEPA H 14
filter); the air pressure was controlled at 50 Pa.
Abbreviations
(Epo): Erythropoietin; (O2): oxygen; (tg6): C57BL/6-
TgN(PDGFBEPO)321Zbz, transgenic mouse line overex-
pressing human erythropoietin; (wt): wild type.
Authors' contributions
BS initiated the study, conducted postoperative intensive
care and treadmill exercise, analyzed the data, interpreted
the results, and drafted the manuscript.
AR coordinated the study, analyzed the data, prepared the
figures, and helped with data acquisition and manuscript
preparation.
JV and MG participated in the design of the study and con-
tributed to manuscript revision.
MA implanted the telemetric transmitters, developed the
modification of the surgical technique, conceived the
postoperative intensive care regimen, and participated in
interpretation of data, and drafting and revision of the
manuscript. All authors read and approved the final man-
uscript.
Acknowledgements
The authors kindly thank the technicians of the Institute of Diagnostic Radi-
ology, University Hospital Zurich, for their excellent support in taking X-
ray pictures of transmitter-bearing mice. We also thank Helen Rothnie for 
helpful suggestions and critical reading of the manuscript. This work was 
sponsored by the Forschungskredit of the University of Zurich, the Swiss 
Federal Veterinary Office, and the Zurich Center for Integrative Human 
Physiology.
References
1. Butz GM, Davisson RL: Long-term telemetric measurement of
cardiovascular parameters in awake mice: a physiological
genomics tool.  Physiological genomics 2001, 5(2):89-97.
2. Clement JG, Mills P, Brockway B: Use of telemetry to record
body temperature and activity in mice.  J Pharmacol Methods
1989, 21(2):129-140.
3. Feng M, Whitesall S, Zhang Y, Beibel M, D'Alecy L, DiPetrillo K: Val-
idation of volume-pressure recording tail-cuff blood pressure
measurements.  American journal of hypertension 2008,
21(12):1288-1291.
4. Kramer K, Kinter LB: Evaluation and applications of radiote-
lemetry in small laboratory animals.  Physiological genomics 2003,
13(3):197-205.
5. Kubota Y, Umegaki K, Kagota S, Tanaka N, Nakamura K, Kunitomo
M, Shinozuka K: Evaluation of blood pressure measured by tail-
cuff methods (without heating) in spontaneously hyperten-
sive rats.  Biol Pharm Bull 2006, 29(8):1756-1758.
6. Whitesall SE, Hoff JB, Vollmer AP, D'Alecy LG: Comparison of
simultaneous measurement of mouse systolic arterial blood
pressure by radiotelemetry and tail-cuff methods.  American
journal of physiology 2004, 286(6):H2408-2415.
7. Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE: Recommen-
dations for blood pressure measurement in humans and
experimental animals: part 2: blood pressure measurement
in experimental animals: a statement for professionals from
the Subcommittee of Professional and Public Education of
the American Heart Association Council on High Blood
Pressure Research.  Arterioscler Thromb Vasc Biol 2005,
25(3):e22-33.
8. Sullivan MJ, Hawthorne MH: Exercise intolerance in patients
with chronic heart failure.  Prog Cardiovasc Dis 1995, 38(1):1-22.
9. Ba A, Delliaux S, Bregeon F, Levy S, Jammes Y: Post-exercise heart
rate recovery in healthy, obeses, and COPD subjects: rela-
tionships with blood lactic acid and PaO2 levels.  Clin Res Car-
diol 2009, 98(1):52-58.
10. Brown RD, Thoren P, Steege A, Mrowka R, Sallstrom J, Skott O,
Fredholm BB, Persson AE: Influence of the adenosine A1 recep-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Veterinary Research 2009, 5:28 http://www.biomedcentral.com/1746-6148/5/28
Page 11 of 11
(page number not for citation purposes)
tor on blood pressure regulation and renin release.  Am J Phys-
iol Regul Integr Comp Physiol 2006, 290(5):R1324-1329.
11. Chen Y, Joaquim LF, Farah VM, Wichi RB, Fazan R Jr, Salgado HC,
Morris M: Cardiovascular autonomic control in mice lacking
angiotensin AT1a receptors.  Am J Physiol Regul Integr Comp Physiol
2005, 288(4):R1071-1077.
12. Ruschitzka FT, Wenger RH, Stallmach T, Quaschning T, de Wit C,
Wagner K, Labugger R, Kelm M, Noll G, Rulicke T, et al.: Nitric
oxide prevents cardiovascular disease and determines sur-
vival in polyglobulic mice overexpressing erythropoietin.
Proc Natl Acad Sci USA 2000, 97(21):11609-11613.
13. Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T,
Gassmann M: Increased cerebral infarct volumes in polyglobu-
lic mice overexpressing erythropoietin.  J Cereb Blood Flow
Metab 2001, 21(7):857-864.
14. Kramer K, Kinter L, Brockway BP, Voss HP, Remie R, Van Zutphen
BL: The use of radiotelemetry in small laboratory animals:
recent advances.  Contemp Top Lab Anim Sci 2001, 40(1):8-16.
15. Mills PA, Huetteman DA, Brockway BP, Zwiers LM, Gelsema AJ,
Schwartz RS, Kramer K: A new method for measurement of
blood pressure, heart rate, and activity in the mouse by radi-
otelemetry.  J Appl Physiol 2000, 88(5):1537-1544.
16. Van Vliet BN, Chafe LL, Antic V, Schnyder-Candrian S, Montani JP:
Direct and indirect methods used to study arterial blood
pressure.  J Pharmacol Toxicol Methods 2000, 44(2):361-373.
17. Carlson SH, Wyss JM: Long-term telemetric recording of arte-
rial pressure and heart rate in mice fed basal and high NaCl
diets.  Hypertension 2000, 35(2):E1-5.
18. Davis ME, Cai H, McCann L, Fukai T, Harrison DG: Role of c-Src in
regulation of endothelial nitric oxide synthase expression
during exercise training.  American journal of physiology 2003,
284(4):H1449-1453.
19. Johnston NA, Bosgraaf C, Cox L, Reichensperger J, Verhulst S, Patten
C Jr, Toth LA: Strategies for refinement of abdominal device
implantation in mice: strain, carboxymethylcellulose, ther-
mal support, and atipamezole.  J Am Assoc Lab Anim Sci 2007,
46(2):46-53.
20. Van Vliet BN, McGuire J, Chafe L, Leonard A, Joshi A, Montani JP:
Phenotyping the level of blood pressure by telemetry in
mice.  Clin Exp Pharmacol Physiol 2006, 33(11):1007-1015.
21. Wagner KF, Katschinski DM, Hasegawa J, Schumacher D, Meller B,
Gembruch U, Schramm U, Jelkmann W, Gassmann M, Fandrey J:
Chronic inborn erythrocytosis leads to cardiac dysfunction
and premature death in mice overexpressing erythropoie-
tin.  Blood 2001, 97(2):536-542.
22. Shibata J, Hasegawa J, Siemens HJ, Wolber E, Dibbelt L, Li D, Kat-
schinski DM, Fandrey J, Jelkmann W, Gassmann M, et al.: Hemosta-
sis and coagulation at a hematocrit level of 0.85: functional
consequences of erythrocytosis.  Blood 2003,
101(11):4416-4422.
23. Vogel J, Kiessling I, Heinicke K, Stallmach T, Ossent P, Vogel O, Aul-
mann M, Frietsch T, Schmid-Schonbein H, Kuschinsky W, et al.:
Transgenic mice overexpressing erythropoietin adapt to
excessive erythrocytosis by regulating blood viscosity.  Blood
2003, 102(6):2278-2284.
24. Bogdanova A, Mihov D, Lutz H, Saam B, Gassmann M, Vogel J:
Enhanced erythro-phagocytosis in polycythemic mice over-
expressing erythropoietin.  Blood 2007, 110(2):762-769.
25. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, Ill-
gen-Wilcke B: Recommendations for the health monitoring of
rodent and rabbit colonies in breeding and experimental
units.  Laboratory animals 2002, 36(1):20-42.